InvestSMART

Ryman Healthcare Limited (ASX: RYM) - Announcements

Current share price for RYM : $1.720 0.05 (2.82%)+

ASX company news and announcements for Ryman Healthcare Limited (RYM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Ryman Healthcare Limited (RYM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Ryman Healthcare Limited (RYM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Ryman Healthcare Limited (RYM)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$1,747 2026 Annual Shareholders Meeting voting results 28 Jul 2026 1:07PM $1.890 $1.720 fallen by 8.99%
$1,747 Ryman Healthcare Limited - 2026 Annual Meeting CEO and Chair 28 Jul 2026 8:09AM $1.880 $1.720 fallen by 8.51%
$1,747 Ryman Healthcare Limited - 2026 Annual Meeting Presentation 28 Jul 2026 8:06AM $1.880 $1.720 fallen by 8.51%
$1,747 Ryman Healthcare Limited - 2026 Annual Meeting NZX & ASX 28 Jul 2026 8:06AM $1.880 $1.720 fallen by 8.51%
$1,747 Climate related disclosures report 28 Jul 2026 7:30AM $1.880 $1.720 fallen by 8.51%
$1,747 First quarter trading update 14 Jul 2026 7:30AM $1.780 $1.720 fallen by 3.37%
$1,747 Change in substantial holding 1 Jul 2026 3:09PM $1.860 $1.720 fallen by 7.53%
$1,747 Change in substantial holding 1 Jul 2026 3:08PM $1.860 $1.720 fallen by 7.53%
$1,747 Ryman Healthcare Limited - Proxy Form 2026 26 Jun 2026 7:30AM $1.870 $1.720 fallen by 8.02%
$1,747 Ryman Healthcare Limited - Notice of Meeting 2026 26 Jun 2026 7:30AM $1.870 $1.720 fallen by 8.02%
$1,747 ASX Listing Rule 1.15.3 24 Jun 2026 7:30AM $1.840 $1.720 fallen by 6.52%
$1,747 Capital Change Notice - RYM010 Bonds 22 Jun 2026 1:44PM $1.865 $1.720 fallen by 7.77%
$1,747 2026 Governance Presentation 12 Jun 2026 7:30AM $1.855 $1.720 fallen by 7.28%
$1,747 Final terms sheet for retail bond offer 11 Jun 2026 12:19PM $1.840 $1.720 fallen by 6.52%
$1,747 Ryman releases final terms sheet for retail bond offer 11 Jun 2026 12:18PM $1.840 $1.720 fallen by 6.52%
$1,747 Cleansing notice for exchange mechanism for RYM010 bonds 11 Jun 2026 12:12PM $1.840 $1.720 fallen by 6.52%
$1,747 Ryman sets interest rate for retail bond offer 11 Jun 2026 11:42AM $1.840 $1.720 fallen by 6.52%
$1,747 Ryman closes its retail bond offer 11 Jun 2026 11:23AM $1.840 $1.720 fallen by 6.52%
$1,747 Ryman Healthcare Limited - Retail bond presentation 9 Jun 2026 7:31AM $1.845 $1.720 fallen by 6.78%
$1,747 Ryman Healthcare Limited - Indicative terms sheet 9 Jun 2026 7:31AM $1.845 $1.720 fallen by 6.78%
$1,747 Ryman Healthcare Limited - Ryman launches retail bond offer 9 Jun 2026 7:30AM $1.845 $1.720 fallen by 6.78%
$1,747 Ryman Healthcare Limited - Cleansing notice 9 Jun 2026 7:30AM $1.845 $1.720 fallen by 6.78%
$1,747 Ryman Healthcare Limited - Corporate Governance Statement 5 Jun 2026 7:30AM $1.900 $1.720 fallen by 9.47%
$1,747 Ryman Healthcare Limited - FY26 Annual Report 5 Jun 2026 7:30AM $1.900 $1.720 fallen by 9.47%
$1,747 Ongoing Disclosure Notice for Hamish Rumbold 5 Jun 2026 7:30AM $1.900 $1.720 fallen by 9.47%

1 - 25 of 66 results

Page 1 of 3

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.